Quantum Biopharma Ltd (QNTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 3,312 | 8,832 | 9,845 | 6,660 | 7,254 |
| Operating Income | -3,312 | -8,832 | -9,845 | -6,660 | -7,254 |
| Interest Expense | 0 | 0 | 1 | 0 | 16 |
| Other Income | 2,180 | 3,341 | -112 | 512 | 141 |
| Pre-tax Income | -1,131 | -5,490 | -9,958 | -6,148 | -7,129 |
| Net Income Continuous | -1,131 | -5,490 | -9,958 | -6,148 | -7,129 |
| Minority Interests | -71 | N/A | N/A | N/A | N/A |
| Net Income | $-1,060 | $-5,490 | $-9,958 | $-6,148 | $-7,129 |
| EPS Basic Total Ops | -1.88 | -9.09 | -16.88 | -9.74 | -12.34 |
| EPS Basic Continuous Ops | -1.88 | -9.09 | -16.60 | -10.35 | -12.12 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.06 | N/A |
| EPS Diluted Total Ops | -1.88 | -9.09 | -16.88 | -9.74 | -12.34 |
| EPS Diluted Continuous Ops | -1.88 | -9.09 | -16.60 | -10.35 | -12.12 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.06 | N/A |
| EBITDA(a) | $-3,165 | $-7,724 | $-8,715 | $-5,506 | $-6,108 |